Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2000, p. 1804-1806, Vol. 38, No. 5
Department of Pediatrics, University
Hospital, Innsbruck,1 Children's
Hospital, Leoben,2 and
Wyeth-Lederle, Vienna,3 Austria, and
Institute for Microbiology and Virology, Bochum,
Germany4
Received 23 August 1999/Returned for modification 8 December
1999/Accepted 21 February 2000
To assess the potential benefits of a reassortant tetravalent
rotavirus vaccine, we investigated stool specimens from children in
three different groups by reverse transcription-PCR (RT-PCR) for
rotavirus G and P types: (i) children not hospitalized with community-acquired rotavirus-acute gastroenteritis (RV-AGE), (ii) children hospitalized for RV-AGE, and (iii) children with nosocomially acquired RV-AGE. From a total of 553 samples investigated, 335 were
positive by enzyme-linked immunosorbent assay, of which 294 (88%)
were positive by RT-PCR. Among the RT-PCR-positive samples, the predominant types were G1P[8] (84%), followed by G4P[8] (9%) and G3P[8] (2%). No differences between the three groups were observed, suggesting that community vaccination will diminish the
most cost-relevant cases of hospitalizations and nosocomial infections.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Distribution of Rotavirus VP4 Genotypes and VP7 Serotypes among
Nonhospitalized and Hospitalized Patients with Gastroenteritis and
Patients with Nosocomially Acquired Gastroenteritis in
Austria
*
Corresponding author. Mailing address: Department of
Pediatrics, Innsbruck, University Hospital, Anichstrasse 35, A-6020
Innsbruck, Austria. Phone: 43-512-504-3501. Fax: 43-512-504-3484. E-mail: Martin.Fruehwirth{at}uibk.ac.at.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»